Title |
Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group |
|---|---|
Involved |
Hans-Joachim Lück (Verfasser)
Andreas Du Bois (Verfasser) Sibylle Loibl (Verfasser) Iris Schrader (Verfasser)
Jens Huober (Verfasser)
Volker Heilmann (Verfasser) Matthias Wilhelm Beckmann (Verfasser) Ann Stähler (Verfasser) Christian Jackisch (Verfasser) Michael Hubalek (Verfasser) Barbara Richter (Verfasser) Elmar Stickeler (Verfasser) Holger Eidtmann (Verfasser) Christoph Thomssen (Verfasser) Michael Untch (Verfasser) Kerstin Wollschläger (Verfasser) Tibor Schuster (Verfasser) Gunter von Minckwitz (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Breast cancer research and treatment 139, 3, 15.6.2013, date:6.2013, Seite 779-787 |
Published |
2013 |
Language |
|
Country |
|
Topic |
|
Subject |
Oncology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2019101101252397337112 (URN) |
Record ID |
1196868972 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: